Ticker
RLYBCompany Name
RALLYBIO CORPSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Current Assets | Current Liabilities | Working Capital |
---|---|---|---|
6/30/2025 | $ 50.27M | $ 5.04M | $ 45.23M |
3/31/2025 | $ 57.38M | $ 3.91M | $ 53.47M |
12/31/2024 | $ 67.84M | $ 6.24M | $ 61.6M |
9/30/2024 | $ 78.23M | $ 8.19M | $ 70.04M |
6/30/2024 | $ 91.44M | $ 12.16M | $ 79.28M |
3/31/2024 | $ 98.55M | $ 10.09M | $ 88.46M |
12/31/2023 | $ 114.79M | $ 9.26M | $ 105.53M |
9/30/2023 | $ 132.42M | $ 9.4M | $ 123.02M |
6/30/2023 | $ 146.83M | $ 8.05M | $ 138.78M |
3/31/2023 | $ 161.28M | $ 6.8M | $ 154.48M |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
AssetsC - LiabilitesC
(=) Working Capital
Working Capital for RALLYBIO CORP is calculated as follows: AssetsC [ $ 141.26M ] - LiabilitesC [ $ 5.84M ]
(=) Working Capital [ $ 135.42M ]
Minimum
Jun 30, 2025
Maximum
Sep 30, 2021
Average
Median
filtered constituents | 2.78K |
---|---|
min | $ -465.2M |
max | $ 607.04M |
average | $ 96.5M |
median | $ 32.21M |
std | $ 173.86M |